Moderna (MRNA) hits 52-week highs after Q3 earnings
FROM THE WIRE · FINANCE.YAHOO.COM
Moderna MRNA) stock has surged as much as 10% in Friday's trading session, reaching a fresh 52-week high of $267 a share after the biotechnology giant delivered much stronger-than-expected Q3 results. The rally comes as investors increasingly gravitate toward healthcare stocks…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishMuch stronger-than-expected quarterly results lifted the stock amid a rotation into healthcare.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna stock rose as much as 10% in Friday's session.
- 02The price reached $267, a fresh 52-week high.
- 03Q3 results were much stronger than expected.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Moderna, Inc.264.13 USD-0.65%today +9.39%Positive Merck & Co., Inc.146.46 USD-0.05%today -0.33%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets